These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36388944)

  • 1. Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2.
    Scalabrin S; Becco A; Vitale A; Nuzzi R
    Front Med (Lausanne); 2022; 9():999251. PubMed ID: 36388944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2.
    Scalabrin S; Becco A; Vitale A; Nuzzi R
    Front Med (Lausanne); 2022; 9():1081686. PubMed ID: 36438032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra).
    Dhillon S; Curran MP
    Paediatr Drugs; 2008; 10(5):337-47. PubMed ID: 18754700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.
    Maldonado MD; Romero-Aibar J
    Brain Behav Immun Health; 2021 Dec; 18():100381. PubMed ID: 34746880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to Vaccine-preventable Viral Infections in Australians Being Evaluated for Liver Transplantation.
    Gardiner A; Liu K; Bonnichsen M; Joshi V; Davis RJ; Strasser SI
    Transplantation; 2019 Nov; 103(11):2318-2322. PubMed ID: 31283670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
    Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL
    Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases.
    Papasavvas I; de Courten C; Herbort CP
    J Ophthalmic Inflamm Infect; 2021 Sep; 11(1):28. PubMed ID: 34529153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model.
    Shin D; Shin Y; Kim E; Nam H; Nan H; Lee J
    BMC Immunol; 2022 Jun; 23(1):27. PubMed ID: 35658899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N; Tsumura N; Toyomasu K; Sagawa K
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of Varicella-Zoster Virus Keratitis After SARS-CoV-2 Vaccination.
    Ryu KJ; Kim DH
    Cornea; 2022 May; 41(5):649-650. PubMed ID: 35383620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
    Cheuk DK; Chiang AK; Lee TL; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2011 Mar; (3):CD006505. PubMed ID: 21412895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of varicella (VZV) vaccination: an update for the clinician.
    Wang L; Zhu L; Zhu H
    Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
    Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
    Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the antibodies against measles, rubella, mumps and varicella-zoster viruses in sera from the medical staffs].
    Shiraishi T; Nakagawa M; Nakagawa Y; Tominaga M; Yoshitani S
    Kansenshogaku Zasshi; 2005 May; 79(5):322-8. PubMed ID: 15977572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New viral vaccines.
    Arvin AM; Greenberg HB
    Virology; 2006 Jan; 344(1):240-9. PubMed ID: 16364754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.